Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program.
Arbanas JC, Damberg CL, Leng M, Harawa N, Sarkisian CA, Landon BE, Mafi JN. Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program. JAMA Intern Med. 2023 08 01; 183(8):885-889.